文献速递传染病防控与疫情报告免疫规划

纯化贝纳柯克斯体I相脂多糖免疫可在小鼠中提供部分保护且不依赖于联合接种的腺病毒载体疫苗

Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.
PubMed 文献 · Vaccine · 2023-04-08

本研究评估了纯化贝纳柯克斯体I相脂多糖(LPS)与腺病毒载体疫苗联合免疫在小鼠中的免疫原性和保护效果。腺病毒载体疫苗单独可诱导强细胞免疫,但该反应与小鼠保护不相关;而LPS接种与细菌攻击后体重下降减少显著相关,且不依赖于是否联合腺病毒载体疫苗,支持基于LPS的进一步疫苗开发。

要点

  • 腺病毒载体疫苗单独诱导强细胞免疫,但该免疫反应与小鼠保护不相关。
  • LPS接种与细菌攻击后体重下降减少显著相关。
  • LPS的保护作用不依赖于联合接种腺病毒载体疫苗。

核心结论

  • LPS接种与细菌攻击后体重下降减少显著相关,且不依赖于联合接种腺病毒载体疫苗,支持基于LPS的进一步疫苗开发。

研究设计与样本

  • 研究合成了编码贝纳柯克斯体单一或融合抗原的多种疫苗构建体,评估了腺病毒载体构建体联合LPS配制后的免疫原性和保护效果。

主要发现

  • 腺病毒载体疫苗构建体单独可诱导强细胞免疫,但该反应与小鼠保护不相关。
  • LPS接种与细菌攻击后体重下降减少显著相关,且不依赖于联合接种腺病毒载体疫苗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Q fever is a highly infectious zoonosis caused by the Gram-negative bacterium Coxiella burnetii. The worldwide distribution of Q fever suggests a need for vaccines that are more efficacious, affordable, and does not induce severe adverse reactions in vaccine recipients with pre-existing immunity against Q fever. Potential Q fever vaccine antigens include lipopolysaccharide (LPS) and several C. burnetii surface proteins. Antibodies elicited by purified C. burnetii lipopolysaccharide (LPS) correlate with protection against Q fever, while antigens encoded by adenoviral vectored vaccines can induce cellular immune responses which aid clearing of intracellular pathogens. In the present study, the immunogenicity and the protection induced by adenoviral vectored constructs formulated with the addition of LPS were assessed. Multiple vaccine constructs encoding single or fusion antigens from C. burnetii were synthesised. The adenoviral vectored vaccine constructs alone elicited strong cellular immunity, but this response was not correlative with protection in mice. However, vaccination with LPS was significantly associated with lower weight loss post-bacterial challenge independent of co-administration with adenoviral vaccine constructs, supporting further vaccine development based on LPS.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Dold C, Zhu H, Silva-Reyes L, et al. Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines. Vaccine. 2023. PMID: 37037709. doi:10.1016/j.vaccine.2023.04.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。